Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

THYMOGLOBULINE for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 40 adverse event reports in the FDA FAERS database where THYMOGLOBULINE was used for Bone marrow conditioning regimen.

Most Reported Side Effects for THYMOGLOBULINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 26 23.9% 5 21
Pyrexia 13 11.9% 6 9
Acute graft versus host disease 10 9.2% 6 2
Cytomegalovirus infection 10 9.2% 4 6
Pneumonia 10 9.2% 7 5
Cytomegalovirus viraemia 9 8.3% 4 7
Post transplant lymphoproliferative disorder 9 8.3% 7 2
Renal impairment 6 5.5% 3 5
Thrombotic microangiopathy 6 5.5% 5 5
Neutrophil count decreased 5 4.6% 2 4
Staphylococcal sepsis 5 4.6% 3 4

Other Indications for THYMOGLOBULINE

Aplastic anaemia (37) Acute graft versus host disease (8) Kidney transplant rejection (5) Product used for unknown indication (5)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

THYMOGLOBULINE Full Profile All Bone marrow conditioning regimen Drugs THYMOGLOBULINE Demographics THYMOGLOBULINE Timeline